Back to Search

JEANA DEPAMPHILIS, PHARMD

PHARMD

Pharmacist

NPI: 1033409735Individual

Specialties, Licenses & Credentials

PharmacistPrimary

Pharmacist

Code: 183500000X

4416(RI)

Research & Publications (7)

Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.
PMID 19676125·Hepatology·2009
4-observational
Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
PMID 18314217·J Hepatol·2008
8-other
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
PMID 18156990·J Acquir Immune Defic Syndr·2008
2-rct
Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
PMID 17457912·J Med Virol·2007
8-other
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection.
PMID 17086057·AIDS·2006
2-rct
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy.
PMID 15316334·AIDS·2004
3-trial
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C.
PMID 11172346·Hepatology·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1665 MINERAL SPRING AVE
NORTH PROVIDENCE, RI 02904

Quick Facts

NPI
1033409735
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
7

Are you this provider?

Claim Your Profile